Early-Onset Cancer in the Gastrointestinal Tract Is on the Rise-Evidence and Implications.

Irit Ben-Aharon, Hanneke W M van Laarhoven, Elisa Fontana, Radka Obermannova, Magnus Nilsson, Florian Lordick

Journal: Cancer discovery 2023;13(3):538-551

PMID: 36757194

Abstract

UNLABELLED

Epidemiologic data indicate a significant increase in the incidence of colorectal cancer in younger populations in the past three decades. Moreover, recent evidence also demonstrates a similar trend in gastric, pancreatic, and biliary tract cancers. A majority of these early-onset cases are sporadic and lack hereditary or familial background, implying a potential key role for behavioral, lifestyle, nutritional, microbial, and environmental factors. This review explores the current data on early-onset gastrointestinal cancer, exploring the etiology, unique treatment considerations for this population, future challenges, as well as implications for research and practice.

SIGNIFICANCE

The worrisome trend of an increasing incidence of early-onset gastrointestinal cancers appears to be correlated with nonhereditary etiologies in which behavioral, lifestyle, nutritional, microbial, and environmental factors, as well as host mechanisms, may play a key role. Further epidemiologic and pathogenetic research is urgently needed to better understand the underlying mechanisms and to develop preventive strategies and tailored early detection. Young patients with gastrointestinal cancer face unique challenges and unmet needs. These must be addressed in the future management of the disease to minimize treatment-related somatic morbidity and prevent psychosocial sequelae.

©2023 American Association for Cancer Research.

Address: Division of Oncology, Rambam Health Care Center, Haifa, Israel.; Rappaport Faculty of Medicine, Technion, Haifa, Israel.; Gastrointestinal Tract Cancer Group, European Organization for Treatment and Research of Cancer (EORTC), Brussels, Belgium.; Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, the Netherlands.; Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Sarah Cannon Research Institute, London, United Kingdom.; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Division of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden.; University Cancer Center Leipzig (UCCL) and 2nd Medical Department (Oncology, Gastroenterology, Hepatology, Pneumology and Infectiology), University Medicine Leipzig, Leipzig, Germany.

Link outs

Free resources

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.